There are 2789 resources available
1381P - Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577
Presenter: Markus Moehler
Session: ePoster Display
1382P - Phase Ib/II open-label, randomised evaluation of second-line atezolizumab (atezo) + linagliptin (lina) vs ramucirumab (ram) + paclitaxel (pac) in MORPHEUS-gastric cancer
Presenter: Jeeyun Lee
Session: ePoster Display
1383P - Phase I study of the irreversible FGFR inhibitor futibatinib in Japanese patients with advanced solid tumors: Updated dose expansion results and activity in gastric cancer
Presenter: Yasutoshi Kuboki
Session: ePoster Display
1384P - DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial
Presenter: Samuel Klempner
Session: ePoster Display
1385P - Phase II study of neoadjuvant camrelizumab combined with chemoradiation for locally advanced proximal gastric cancer (Neo-PLANET, NCT03631615)
Presenter: Zhao-qing Tang
Session: ePoster Display
1333P - Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study
Presenter: Go Saito
Session: ePoster Display
1335P - Updated results from a phase I/II study of anlotinib plus docetaxel vs docetaxel as second-line treatment of advanced non-small cell lung cancer (NSCLC)
Presenter: Yong Fang
Session: ePoster Display
1337P - Clinical study of apatinib combined with radiation therapy in advanced non-small cell lung cancer patients with brain metastasis
Presenter: Xiaqin Zhang
Session: ePoster Display